DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Stiripentol
Stiripentol
Stiripentol with an Average Age of 9.1 Years
10|18 Stiripentol Use in Children with Refractory Seizures
Preferred Drug List 4-Tier
Audit of Use of Stiripentol in Adults with Dravet Syndrome
Therapeutic Class Overview Anticonvulsants
Primidone SERB 50Mg and 250Mg Tablets Primidone
Utah Medicaid Dur Report March 2019
Stiripentol for Continuation in Adults with Dravet Syndrome (PDF)
New Antiepileptic Drugs
Diacomit, INN-Stiripentol
Shared Care Guideline Stiripentol Use for SCN1A Related and Severe Myoclonic Epilepsies in Infancy
Pharmaceuticals and Medical Devices Safety Information No
PDL)/Non-Preferred Drug List (NPDL
Product Monograph Diacomit
Novel Antiepileptic Drugs
Medicaid List of Covered Drugs (Formulary)
Diacomit® (Stiripentol Capsules and Powder for Oral Suspension)
Stiripentol in Dravet Syndrome: Results of a Retrospective U.S. Study *Elaine C
Top View
DIACOMIT (Stiripentol)
CDR Clinical Review Report on Diacomit (Stiripentol)
Fenfluramine for Treatment-Resistant Seizures in Patients with Dravet Syndrome Receiving Stiripentol-Inclusive Regimens a Randomized Clinical Trial
Diacomit 100 Mg Hard Capsules
Efficacy of Stiripentol in Dravet Syndrome with Or Without SCN1A Mutations
Drug Benefit Guide
Product Monograph DIACOMIT® (Stiripentol) in the Treatment of Seizures Associated with Dravet Syndrome in Patients 2 Years of Age and Older Taking Clobazam
Medicare Model Guidelines Draft V8.0 1 of 97
Diacomit, INN: Stiripentol
DIACOMIT® (Stiripentol) Drug Interactions DIACOMIT® (Stiripentol) Drug Interactions
Wo 2007/044693 A2
DIACOMIT (Stiripentol) RATIONALE for INCLUSION in PA PROGRAM
Therapeutic Class Overview Anticonvulsants
Newer Anti-Epileptic Drugs
Application Number
An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs
January February 2019 Clinical Rx Forum Newsletter.Pub
Stiripentol (Diacomit®) EOCCO POLICY
Australian Public Assessment Report for Stiripentol
Long-Term Safety and Efficacy of Stiripentol for the Treatment Of
206709Orig1s000 207223Orig1s000
Stiripentol New Medicine Recommendation
Audit of Use of Stiripentol in Adults with Dravet Syndrome
Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome
(12) United States Patent (10) Patent No.: US 9,603,815 B2 Ceulemens Et Al
Stiripentol (Diacomit) Reference Number: ERX.NPA.100 Effective Date: 12.01.18 Last Review Date: 11.20 Line of Business: Commercial, Medicaid Revision Log
Treatment of Dravet Syndrome
Stiripentol - Emerge Health Australia Pty Ltd - PM-2016-02336-1-1 FINAL 12 November 2019
Clinical Policy: Stiripentol (Diacomit)
Reduced Pharmacoresistance to Stiripentol During Prolonged Status Epilepticus
22-The-Therapeutic-Effect-Of-Stiripentol.Pdf